Las Vegas, NV -- (SBWIRE) -- 12/27/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Rite Aid Corporation (NYSE:RAD), Alcoa Inc(NYSE:AA), Pfizer Inc.(NYSE:PFE), Oracle Corporation (NYSE:ORCL)
Rite Aid Corporation (NYSE:RAD) was a volume gainer of 12.33 million shares and the average volume of the stock remained 28.89 million shares. The stock opened the session at $5.21 and finished at the end of the day at $5.17 and the stock plunged -0.19%.The market capitalization of the stock remained 4.74 billion. Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards.
Has RAD Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Alcoa Inc(NYSE:AA) exchanged 12.21 million shares and the average volume remained 21.02 million shares. The stock closed the session at $10.43 with the gain of 0.68%. Alcoa Inc. engages in the production and management of primary aluminum, fabricated aluminum, and alumina. The company operates in four segments: Alumina, Primary Metals, Global Rolled Products, and Engineered Products and Solutions. The Alumina segment engages in mining of bauxite, which is then refined into alumina.
Will AA Continue To Move Higher? Find Out Here
Pfizer Inc.(NYSE:PFE) enhanced 0.86% and its closing price was $30.55. The volume of the stock was 12.06 million shares and the average volume remained 25.95 million shares. The market capitalization of the stock remained 198.00 billion. Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimers disease, pain, respiratory, and smoking cessation therapeutic and disease areas.
Why Should Investors Buy PFE After The Recent Gain? Just Go Here and Find Out
Oracle Corporation (NYSE:ORCL) exchanged 11.52 million shares in the previous trading session, and its average trading remained 21.17 million shares. ORCL advanced 0.99% and it closed the trading at $37.69. The market capitalization of the stock remained 169.51 billion. Oracle Corporation develops, manufactures, markets, hosts, and supports database and middleware software, applications software, and hardware systems. It licenses database and middleware software, including database and database management, application server and cloud application.
For How Long ORCL’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)